The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Parkinson's Disease
This Medical Stock Soared Over 80% In Pre-Market After Advancing Gene Therapy Program For ALS, Alzheimer's And Parkinson's Diseases
Comedian And 'Curb Your Enthusiasm' Fame Richard Lewis Dies At 76
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment
Comedian And 'Curb Your Enthusiasm' Fame Richard Lewis Dies At 76
Study Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's Treatment
Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'
Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Worms Get The Munchies Like The Rest Of Us, Finds Study 'With Profound Implications For Human Health'
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
Elon Musk Says His Neuralink Chip Could Treat Paralysis, Stroke And Brain Injury
Read More...
Parkinson's Disease Recent News
Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease
Alterity Therapeutics's (NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease.
Recent Survey Finds Many Parkinson's Disease Patients Turn To Cannabis
This article by Chynna Pearson was originally published on Cannabis & Tech Today, and appears here with permission.
Zelira Therapeutics Will Partner With The Parkinson's Foundation
FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment
Seelos Therapeutics Shares Rally Following Deal For Gene Therapy Program
Why Seelos Therapeutics Shares Are Surging Out Of The Gate
EPA Amends Proposed Regulation Of Syngenta Ingredient In Response To Public Comments
Anavex Life Sciences Jumps 28% After Promising Results From Parkinson's Trial
Goldman Initiates Impax Labs With Sell Rating, $33 Target
IBM Teams Up With Pfizer To Move Towards Parkinson's Cure
Acadia Continues Huge Rise Following FDA Panel Vote